A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer

por Desar, I M E, Timmer-Bonte, J N H, Burger, D M, van der Graaf, W T A, van Herpen, C M L
Publicado 2010

Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups

por Tomassen, T., Weidema, M. E., Hillebrandt-Roeffen, M. H. S., van der Horst, C., Desar, I. M. E., Flucke, U. E., Versleijen-Jonkers, Yvonne M. H.
Publicado 2022

601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

por Gelderblom, H., Gietema, J.A., Desar, I.M.E., Ajmone, N.M., Jalving, M., Kroep, J.R., Nicolas, V., Vaslin, A., Tobal, K., Purcea, D., van Haren, S.F., Damstrup, L.
Publicado 2020

Sex differences in patients with gastrointestinal stromal tumours: do they exist and does it affect survival?

por IJzerman, N.S., van Werkhoven, E., Mohammadi, M., Hollander, D. den, Bleckman, R.F., Reyners, A.K.L., Desar, I.M.E., Gelderblom, H., Grünhagen, D.J., Mathijssen, R.H.J., Steeghs, N., van der Graaf, W.T.A.
Publicado 2022

Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study

por Desar, I.M.E., ter Voert, E.G.W., Hambrock, Th., van Asten, J.J.A., van Spronsen, D.J., Mulders, P.F.A., Heerschap, A., van der Graaf, W.T.A., van Laarhoven, H.W.M., van Herpen, C.M.L.
Publicado 2011

Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study

por Younger, E., Jones, R.L., den Hollander, D., Soomers, V.L.M.N., Desar, I.M.E., Benson, C., Young, R.J., Oosten, A.W., de Haan, J.J., Miah, A., Zaidi, S., Gelderblom, H., Steeghs, N., Husson, O., van der Graaf, W.T.A.
Publicado 2021